An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to www.epa.gov. This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

A550 PRIA Fee Category

PRIA 4 Fee Determination Decision Tree:

Antimicrobial Active Ingredient Registration for End Use Product


Below is the fee for your selected Fee Category for Fiscal Years 2020-2021

Action Code Description FY'20 - FY'21 Fee Decision Time (months)
A550 New end-use product; uses other than FIFRA §2(mm); non-FQPA product (2) (3) (5) $13,888 9

Do you plan to request either of the following types of waivers?

Waiver Pay Amount
50% waiver You pay ---->>>>> $6,944
75% waiver You pay ---->>>>> $3,472

To pay the fee shown above, go to Paying PRIA Application Fees web page and follow the instructions.

How to submit your application directly to EPA.

Action Code Interpretation

An application for registration of a pesticide product that is not substantially similar or identical in its uses or formulation to products that are currently registered. These applications require product chemistry data (Group A and Group B), acute toxicity data (addressing all 6 endpoints), and possibly leaching data. This type of application would be for a product where a claim of pesticidal activity other than or in addition to contamination, fouling or deterioration caused by bacteria, viruses, fungi, protozoa, algae or slime is made. Refer to FIFRA Section 2(mm) for additional information.

Examples would include:

  • Wood preservatives (e.g., termite claim)
  • Antifoulants
  • Ballast water
  • Any of the above use patterns that would result in a significant increase in the level of exposure (increase in dosage rate, or a change in the route of exposure (fog vs. spray), to the active ingredient of man or other organisms.

An application for a new end-use product using a source of active ingredient that is not yet registered but has an application pending with the Agency for review, will be considered an application for a new product with an unregistered source of active ingredient.

All of the inerts used in the product must be either approved or pending with the Agency for the applicable uses.

For generic data only: Either Formulator’s Exemption or the cite-all method must be used to satisfy the generic data requirements, or a selective citation where the applicant owns all data.

Applicants are encouraged to discuss any requirements for leaching data with the Agency prior to submission of an application.

The Agency will provide the applicant with a pre-decisional determination 2 weeks prior to the PRIA decision review time due date which specifies any label changes that have to be made  in order to grant the requested new product registration. If the label issues cannot be  resolved prior to the PRIA decision review time due date and if a PRIA due date time extension has not been agreed upon, then the Agency will issue to the applicant its  regulatory decision with the specific label changes and supporting documentation on or just before the PRIA decision review time due date. At that time the applicant must either (a) agree to all of the label changes and submit a revised label that incorporates all of these label changes; or (b) does not agree with one or more of the label changes and request up to 30 days to reach agreement with the Agency and submit a revised label that incorporates all of the agreed upon label changes, which the Agency has 2 business days to review; or (c) withdraw the application without prejudice.

Go to the start of the Decision Tree